New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®; FDA recently accepted sNDA filing to review data from DYNAGITO trial for inclusion in Stiolto Respimat label

Press/Media: Press / Media

PeriodMar 29 2018

Media coverage

2

Media coverage

  • TitleNew Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®; FDA recently accepted sNDA filing to review data from DYNAGITO trial for inclusion in Stiolto Respimat label
    Media name/outletPR Newswire
    CountryUnited States
    Date3/29/18
    PersonsAntonio R Anzueto
  • TitleNew Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®; FDA recently accepted sNDA filing to review data from DYNAGITO trial for inclusion in Stiolto Respimat label
    Media name/outletPR Newswire
    CountryUnited States
    Date3/29/18
    PersonsAntonio R Anzueto